Page last updated: 2024-09-04

cyc 202 and Brain Injuries

cyc 202 has been researched along with Brain Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrnes, KR; Faden, AI; Hilton, GD; Stoica, BA1
Byrnes, KR; Faden, AI; Hanscom, M; Kabadi, SV; Loane, DJ; Stoica, BA1

Other Studies

2 other study(ies) available for cyc 202 and Brain Injuries

ArticleYear
Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2008, Volume: 28, Issue:11

    Topics: Animals; Behavior, Animal; Brain Injuries; Cell Death; Cognition; Cyclin-Dependent Kinases; Immunohistochemistry; Male; Microglia; Motor Activity; Neurons; Neuroprotective Agents; Purines; Rats; Rats, Sprague-Dawley; Roscovitine

2008
Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:1

    Topics: Animals; Apoptosis; Behavior, Animal; Blotting, Western; Brain Injuries; Carrier Proteins; Cell Cycle; Cyclin A; Cyclin D1; Cyclin-Dependent Kinases; Disease Models, Animal; Immunohistochemistry; Maze Learning; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Motor Activity; Neurons; Neuroprotective Agents; Purines; Roscovitine; Time Factors

2012